CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813879991
- Phone
- 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +3,805 | $4.30 | $16K | 162,649 |
| 2026-11-05 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −4,000 | $12.36 | $49K | 158,649 |
| 2026-11-05 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,805 | 75,182 | ||
| 2026-09-08 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $4.30 | $17K | 166,844 |
| 2026-09-08 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −8,000 | $21.57 | $173K | 158,844 |
| 2026-09-08 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 78,987 | ||
| 2026-08-13 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +30,000 | $4.30 | $129K | 192,844 |
| 2026-08-13 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −30,000 | $20.26 | $608K | 162,844 |
| 2026-08-13 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 82,987 | ||
| 2026-07-06 | Michaelson Jennifer Chief Scientific Officer | Option exercise 10b5-1 | +4,000 | $4.30 | $17K | 170,844 |
| 2026-07-06 | Michaelson Jennifer Chief Scientific Officer | Sale 10b5-1 | −8,000 | $17.82 | $143K | 162,844 |
| 2026-07-06 | Michaelson Jennifer Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 112,987 | ||
| 2026-06-30 | SUMER JACQUELYN L Chief Legal Officer | Grant or award | +2,470 | $8.60 | $21K | 130,559 |
| 2026-06-30 | Fenton Mary Kay Chief Financial Officer | Grant or award | +1,541 | $8.60 | $13K | 127,921 |
| 2026-06-16 | Rosenberg Anthony Director | Grant or award · Stock Option (Right to Buy) | +25,319 | 25,319 | ||
| 2026-06-16 | Meek David D. Director | Grant or award · Stock Option (Right to Buy) | +25,319 | 25,319 | ||
| 2026-06-16 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +25,319 | 25,319 | ||
| 2026-06-16 | Allen Andrew R Director | Grant or award · Stock Option (Right to Buy) | +21,781 | 21,781 | ||
| 2026-06-16 | Thistle Mary Director | Grant or award · Stock Option (Right to Buy) | +25,319 | 25,319 | ||
| 2026-06-16 | Doyle Mittie Director | Grant or award · Stock Option (Right to Buy) | +21,781 | 21,781 |
Page 1 of 23 · 446 trades